Health Catalyst, Inc. (NASDAQ:HCAT) Stake Lifted by Portolan Capital Management LLC

Portolan Capital Management LLC raised its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 12.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 749,029 shares of the company’s stock after purchasing an additional 85,427 shares during the period. Portolan Capital Management LLC owned 1.23% of Health Catalyst worth $5,296,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Quantbot Technologies LP bought a new position in shares of Health Catalyst in the fourth quarter valued at approximately $29,000. Stoneridge Investment Partners LLC acquired a new position in shares of Health Catalyst in the 4th quarter worth $77,000. Martin Worley Group acquired a new position in shares of Health Catalyst in the 4th quarter valued at $78,000. OneAscent Financial Services LLC purchased a new position in shares of Health Catalyst in the fourth quarter worth approximately $97,000. Finally, ExodusPoint Capital Management LP purchased a new position in Health Catalyst during the 4th quarter worth approximately $107,000. 85.00% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on HCAT shares. Stifel Nicolaus reduced their price objective on Health Catalyst from $10.00 to $5.00 and set a “hold” rating for the company in a research note on Thursday, February 27th. Citigroup cut their price target on shares of Health Catalyst from $10.50 to $10.00 and set a “buy” rating on the stock in a report on Friday, January 10th. KeyCorp upgraded Health Catalyst from a “sector weight” rating to an “overweight” rating and set a $9.00 price target for the company in a research note on Wednesday, January 8th. Canaccord Genuity Group lowered their target price on shares of Health Catalyst from $11.00 to $10.00 and set a “buy” rating on the stock in a research note on Tuesday, January 21st. Finally, Royal Bank of Canada decreased their price target on shares of Health Catalyst from $7.00 to $6.00 and set a “sector perform” rating for the company in a report on Thursday, February 27th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $8.73.

Insider Activity at Health Catalyst

In other news, COO Daniel Lesueur sold 16,902 shares of the company’s stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $4.52, for a total value of $76,397.04. Following the sale, the chief operating officer now directly owns 216,250 shares in the company, valued at approximately $977,450. This represents a 7.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Linda Llewelyn sold 6,441 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $5.43, for a total value of $34,974.63. Following the transaction, the insider now owns 85,819 shares of the company’s stock, valued at $465,997.17. This trade represents a 6.98 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 54,030 shares of company stock valued at $263,269 over the last quarter. 2.50% of the stock is owned by company insiders.

Health Catalyst Trading Up 2.6 %

Shares of HCAT stock opened at $3.93 on Monday. The firm has a fifty day moving average of $4.65 and a 200-day moving average of $6.50. The stock has a market cap of $275.93 million, a price-to-earnings ratio of -2.91 and a beta of 1.43. Health Catalyst, Inc. has a 52-week low of $3.60 and a 52-week high of $9.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.